Enact Holdings, Inc.
At today's price, Enact Holdings, Inc. (ACT) is priced for 9.7% return on equity. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
• Enact is a mono-line private mortgage insurer: it earns a premium for taking the first-loss risk on low-down-payment home loans, and the business is doing well, an adjusted operating return on equity near 12.9% on $272 billion of insurance in force. • The defining risk is its dependence on the housing-finance plumbing: Enact can write the insurance the GSEs accept only by meeting their capital rules, and the filing warns that failing to comply could force it to ⟦"seek the GSEs' prior approval"
Is ACT overvalued? See what's priced in →
243 institutional managers reported holding ACT in 13F filings for the quarter ended 2026-03-31. Together they hold about 19% of the company; the top 10 hold 11%. 34 opened new positions that quarter. Held by BlackRock, Dimensional Fund Advisors, State Street, among others. On the short side, 3.8M shares were sold short as of the 2026-06-15 count, about 3% of shares outstanding (12.4 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
ACT has cut its share count 13% over the past five years, spending $808.86M on repurchases. It pays a dividend, and has paid one every year in our records (6 and counting); the current rate is $0.81 a share annually. Cash returned over the past three years: $426.82M in dividends and $743.89M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at ACT over the trailing three years: 2024: 1 buy totaling $270k. 7 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
ACT's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-03-01 | -8.3% | -2.6% |
| 2023-05-06 | -7.7% | +6.9% |
| 2023-08-05 | +3.6% | -3.5% |
| 2023-11-03 | +1.2% | +0.7% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
ACT's latest 8-K filings: 2026-05-15 (items 5.07); 2026-05-05 (items 2.02, 9.01); 2026-02-03 (items 2.02, 8.01, 9.01); 2025-11-05 (items 2.02, 9.01); 2025-10-01 (items 1.01, 1.02, 2.03, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.